1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease
BackgroundNAFLD, a leading global cause of liver disease, is projected to dominate end-stage liver disease burden. Strongly linked to obesity, type 2 diabetes, and metabolic syndrome, its prevalence and incidence are rising rapidly, yet it remains unclassified by WHO as a priority non-communicable d...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1609816/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850232157095591936 |
|---|---|
| author | Jun Tang Nan Zheng Yu-Xin Yan Nan Zhang Xiao-Mei Ren |
| author_facet | Jun Tang Nan Zheng Yu-Xin Yan Nan Zhang Xiao-Mei Ren |
| author_sort | Jun Tang |
| collection | DOAJ |
| description | BackgroundNAFLD, a leading global cause of liver disease, is projected to dominate end-stage liver disease burden. Strongly linked to obesity, type 2 diabetes, and metabolic syndrome, its prevalence and incidence are rising rapidly, yet it remains unclassified by WHO as a priority non-communicable disease. This study aims to assess the global, regional, and national burden of NAFLD from 1990 to 2021 and provide evidence for future prevention and control strategies.MethodsUsing 2021 Global Burden of Disease (GBD) data, this study analyzed NAFLD prevalence, incidence, mortality, and disability-adjusted life years (DALYs) across 204 countries (1990–2021), stratified by sex, age, and Socio-demographic Index (SDI). Trends were assessed via age-standardized rates (ASR) and estimated annual percentage changes (EAPC), with projections to 2050.ResultsIn 2021, global NAFLD cases surged to 1.268 billion (124.63% increase since 1990), while ASR rose from 12,085.09 to 15,018.07 per 100,000. Middle- and high-SDI regions exhibited steepest rises in incidence and mortality. Oceania, Central and Latin America had highest prevalence; North Africa and the Middle East reported peak incidence. Projections indicate escalating global incidence through 2050, disproportionately affecting females, driven by population growth and aging.ConclusionThe escalating burden underscores urgent need for region-specific interventions, particularly in aging and high-growth populations. Enhanced screening and early intervention are critical to mitigate NAFLD’s expanding impact. This study highlights actionable data to inform global public health strategies, emphasizing tailored prevention and control measures to address evolving epidemiological trends. |
| format | Article |
| id | doaj-art-b3db2ddf61ca476394ca68e4239c353f |
| institution | OA Journals |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-b3db2ddf61ca476394ca68e4239c353f2025-08-20T02:03:16ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-06-011210.3389/fmed.2025.160981616098161990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver diseaseJun TangNan ZhengYu-Xin YanNan ZhangXiao-Mei RenBackgroundNAFLD, a leading global cause of liver disease, is projected to dominate end-stage liver disease burden. Strongly linked to obesity, type 2 diabetes, and metabolic syndrome, its prevalence and incidence are rising rapidly, yet it remains unclassified by WHO as a priority non-communicable disease. This study aims to assess the global, regional, and national burden of NAFLD from 1990 to 2021 and provide evidence for future prevention and control strategies.MethodsUsing 2021 Global Burden of Disease (GBD) data, this study analyzed NAFLD prevalence, incidence, mortality, and disability-adjusted life years (DALYs) across 204 countries (1990–2021), stratified by sex, age, and Socio-demographic Index (SDI). Trends were assessed via age-standardized rates (ASR) and estimated annual percentage changes (EAPC), with projections to 2050.ResultsIn 2021, global NAFLD cases surged to 1.268 billion (124.63% increase since 1990), while ASR rose from 12,085.09 to 15,018.07 per 100,000. Middle- and high-SDI regions exhibited steepest rises in incidence and mortality. Oceania, Central and Latin America had highest prevalence; North Africa and the Middle East reported peak incidence. Projections indicate escalating global incidence through 2050, disproportionately affecting females, driven by population growth and aging.ConclusionThe escalating burden underscores urgent need for region-specific interventions, particularly in aging and high-growth populations. Enhanced screening and early intervention are critical to mitigate NAFLD’s expanding impact. This study highlights actionable data to inform global public health strategies, emphasizing tailored prevention and control measures to address evolving epidemiological trends.https://www.frontiersin.org/articles/10.3389/fmed.2025.1609816/fullnon-alcoholic fatty liver diseaseprevalenceincidencemortalitydisability-adjusted life yearssocio-demographic index |
| spellingShingle | Jun Tang Nan Zheng Yu-Xin Yan Nan Zhang Xiao-Mei Ren 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease Frontiers in Medicine non-alcoholic fatty liver disease prevalence incidence mortality disability-adjusted life years socio-demographic index |
| title | 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease |
| title_full | 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease |
| title_fullStr | 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease |
| title_full_unstemmed | 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease |
| title_short | 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease |
| title_sort | 1990 2021 global regional and national analysis of the burden and trends of non alcoholic fatty liver disease |
| topic | non-alcoholic fatty liver disease prevalence incidence mortality disability-adjusted life years socio-demographic index |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1609816/full |
| work_keys_str_mv | AT juntang 19902021globalregionalandnationalanalysisoftheburdenandtrendsofnonalcoholicfattyliverdisease AT nanzheng 19902021globalregionalandnationalanalysisoftheburdenandtrendsofnonalcoholicfattyliverdisease AT yuxinyan 19902021globalregionalandnationalanalysisoftheburdenandtrendsofnonalcoholicfattyliverdisease AT nanzhang 19902021globalregionalandnationalanalysisoftheburdenandtrendsofnonalcoholicfattyliverdisease AT xiaomeiren 19902021globalregionalandnationalanalysisoftheburdenandtrendsofnonalcoholicfattyliverdisease |